Effect of Blue Light Filtration on Visual Performance
Launched by ALCON RESEARCH · Sep 5, 2013
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cataract surgery in both eyes with no blue light filtering intraocular lenses for at least 3 months;
- • Good ocular health;
- • 20/40 or better vision with best correction in both eyes;
- • Willing to provide voluntary consent and sign informed consent form;
- • Able to competently perform testing;
- • Other protocol-defined inclusion criteria may apply.
- Exclusion Criteria:
- • Ocular pathology, degeneration, or media opacity (cloudiness) that could impact study measurements;
- • Other protocol-defined exclusion criteria may apply.
About Alcon Research
Alcon Research is a leading global company dedicated to advancing eye care through innovative research and development. As a subsidiary of Novartis, Alcon focuses on the development of cutting-edge products and therapies for vision correction and eye health, including surgical, pharmaceutical, and consumer eye care solutions. With a commitment to enhancing the quality of life for patients worldwide, Alcon Research conducts rigorous clinical trials to evaluate the safety and efficacy of its products, ensuring that they meet the highest standards of care. Through collaboration with healthcare professionals and institutions, Alcon remains at the forefront of ophthalmic advancements, driving progress in the field of vision science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Stefani Smith, MS
Study Director
Alcon Research
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials